941 - 950 of 4301 Drugs
Simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension)
Simbrinza (brinzolamide/brimonidine tartrate) 1%/0.2% is a combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist used to reduce intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
Brisdelle (paroxetine capsules 7.5 mg)
Brisdelle (paroxetine) is a selective serotonin reuptake inhibitor (SSRI) used to treat moderate to severe vasomotor menopausal symptoms (VMS) such as hot flashes and night sweats associated with menopause. Brisdelle is not intended to treat any psychiatric condition. Common side effects of Brisdelle include:
Briumvi (ublituximab-xiiy injection)
Briumvi (ublituximab-xiiy) is a CD20-directed cytolytic antibody indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Briviact (brivaracetam oral solution and intravenous injection)
Briviact (brivaracetam) is an antiepileptic drug (AED) indicated as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.
Brixadi (buprenorphine extended-release injection)
Brixadi (buprenorphine) is a partial opioid agonist indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. Brixadi should be used as part of a complete treatment plan that includes counseling and psychosocial support.
Siliq (brodalumab injection for subcutaneous use)
Siliq (brodalumab) injection is a human interleukin-17 receptor A (IL-17RA) antagonist indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies.
Bromday (bromfenac ophthalmic solution)
Bromday (bromfenac) Ophthalmic Solution 0.09% is a nonsteroidal anti-inflammatory drug (NSAID) used to decrease inflammation and relieve pain after cataract surgery.
Xibrom (bromfenac ophthalmic solution)
Xibrom (bromfenac ophthalmic solution) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat swelling and pain caused by cataract surgery.
Prolensa (bromfenac ophthalmic solution)
Prolensa (bromfenac) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat eye pain that arises as the result of cataract surgery.
BromSite (bromfenac ophthalmic solution, 0.075%)
Bromsite (bromfenac) ophthalmic solution 0.075% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.